UCSD Names New Head of Alzheimer’s Study

The project at the center of the dust up between the University of California, San Diego, and the University of Southern California gets a new leader, as the institutions continue to battle in court.

Bob Grant
Bob Grant

Bob Grant is Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.

View full profile.

Learn about our editorial policies.

UCSD Medical CenterWIKIMEDIA, COOLCAESARThe University of California, San Diego, (UCSD) has named a new head of its Alzheimer’s Disease Cooperative Study (ADCS), even as its court battle with the University of Southern California (USC)—over the departure of the former head of the project—rages on. UCSD tapped Howard Feldman, a neurologist from the University of British Columbia in Vancouver, to lead the ADCS. “Dr. Feldman is an extraordinarily accomplished physician and scientist, a thought leader in Alzheimer’s disease clinical research,” Pradeep Khosla, chancellor of UCSD, said in a January 14 statement. “His research—and the many trials he has led—has been vastly influential in the field. His leadership will take ADCS to new levels, and further elevate UC San Diego’s standing as a pioneering institution in Alzheimer’s research and treatment.”

Feldman, whose appointment must first be approved by the National Institute on Aging (a major funder of the project),...

According to Xconomy, the matter has been taken up by federal court, where litigation is still pending.

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?